“We recently developed a mathematical model with the Higher Institute of Health (ISS) and the Fondazione Bruno Kessler to see when we can return to pseudo-normality,” Rezza told the Senate health and hygiene committee, according to the Italian state broadcaster. . Rai.
“Assuming that the vaccine will protect against infection and that the vaccination is effective for at least two years, vaccinating 240,000 people a day will bring us back to normal in seven to 15 months.”
“This can be obtained with a large number of vaccines and maintaining containment (of the coronavirus),” he said.
Italy is currently vaccinating about 100,000 people per day and aims to increase this number to 200,000 by the end of March.
“Today vaccines are increasing,” Rezza said. “The number of available doses will certainly increase in the second half of the 2021 quarter”
“Now we have three (approved vaccines),” he added. “By April we will probably have the fourth and others will arrive in a few months.”
- Italy will be the first EU country to manufacture the Russian Sputnik vaccine
- Italy authorizes the AstraZeneca vaccine for people over 65 years of age
- Italy considers giving a single dose of vaccine to people who have had Covid-19
“In the second quarter of 2021 there will be many more doses than in the first quarter, and we will see the expansion of both the number of vaccinators and people who can be vaccinated.”
As hospital intensive care units are again under pressure, the government is also considering increasing restrictions nationwide, from extending the current night curfew to a nationwide shutdown, according to media reports.
Additional measures could be announced on Friday if the infection rate rises again this week.
However, the government is reportedly divided on what kind of additional restrictions to introduce.
Rezza emphasized to the Senate the importance of controlling infections during the launch of the vaccine.
“Containing the most dangerous variants of today and mitigating the advance of the epidemic is essential to protect the vaccination campaign,” he said.
“Variations are very insidious. We have estimated that the English variant alone results in an increase in transmissibility of between 35 and 36 percent. “
“The Brazilian also slightly reduces the effectiveness of the vaccine. That is why it is necessary to counteract the variations in every way ”.
“Contain and vaccinate is the recipe.”
More studies need to be done before it is known precisely how effective the vaccines are, he said.
“We know that there is high efficacy for most vaccines, but we do not know if they protect against disease or if they block transmission, which is important to know to understand if herd immunity can be achieved.”
“Furthermore, we do not know the duration of protection and the effect of the variants on efficacy.”
George is Digismak’s reported cum editor with 13 years of experience in Journalism